Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,044 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
Kim DW, Chul Cho B, Pachipala K, Kim SW, Wang CL, Chang GC, Ahn MJ, Alvarez R, Chiu CH, Trigo J, Estival A, Karam SD, O'Brien C, Gowda H, Jiang H, Bauman JE. Kim DW, et al. Among authors: wang cl. Lung Cancer. 2024 Apr;190:107530. doi: 10.1016/j.lungcan.2024.107530. Epub 2024 Mar 7. Lung Cancer. 2024. PMID: 38471416 Free article. Clinical Trial.
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status.
Hsu CH, Tseng CH, Chiang CJ, Hsu KH, Tseng JS, Chen KC, Wang CL, Chen CY, Yen SH, Chiu CH, Huang MS, Yu CJ, Tsai YH, Chen JS, Tsai CM, Chou TY, Lin KC, Tsai MH, Lee WC, Ku HY, Liu TW, Yang TY, Chang GC. Hsu CH, et al. Among authors: wang cl. Oncotarget. 2016 Jul 19;7(29):46628-46635. doi: 10.18632/oncotarget.9338. Oncotarget. 2016. PMID: 27191886 Free PMC article.
Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma.
Zheng ZR, Ku HY, Chen KC, Chiang CJ, Wang CL, Chen CY, Tsai CM, Huang MS, Yu CJ, Chen JS, Chou TY, Lee WC, Wang CC, Liu TW, Hsia JY, Chang GC. Zheng ZR, et al. Among authors: wang cc, wang cl. Front Oncol. 2023 Mar 17;13:1063695. doi: 10.3389/fonc.2023.1063695. eCollection 2023. Front Oncol. 2023. PMID: 37007097 Free PMC article.
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma.
Tseng CH, Chiang CJ, Tseng JS, Yang TY, Hsu KH, Chen KC, Wang CL, Chen CY, Yen SH, Tsai CM, Huang MS, Ho CC, Yu CJ, Tsai YH, Chen JS, Chou TY, Tsai MH, Chen HY, Su KY, Chen JJW, Chen HW, Yu SL, Liu TW, Chang GC. Tseng CH, et al. Among authors: wang cl. Oncotarget. 2017 Oct 12;8(58):98384-98393. doi: 10.18632/oncotarget.21842. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228697 Free PMC article.
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma.
Raghav L, Chang YH, Hsu YC, Li YC, Chen CY, Yang TY, Chen KC, Hsu KH, Tseng JS, Chuang CY, Lee MH, Wang CL, Chen HW, Yu SL, Su SF, Yuan SS, Chen JJW, Ho SY, Li KC, Yang PC, Chang GC, Chen HY. Raghav L, et al. Among authors: wang cl. Cancers (Basel). 2020 Mar 23;12(3):755. doi: 10.3390/cancers12030755. Cancers (Basel). 2020. PMID: 32210009 Free PMC article.
2,044 results